|
|
|
40
|
0013AZ
|
LEVOCETIRIZINE 2.5MG/ML SYR (CIR/AHI)
|
LEVOCETIRIZINE
|
LEVOCETIRIZINE
|
60ML
|
C
|
5.71
|
0.10
|
SYRUP
|
0
|
ML
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
0408
|
SECOND GENERATION ANTIHISTAMINES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTIHISTAMINICS
|
|
|
|
|
40
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR/AHI)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
1.90
|
1.90
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
2.07
|
2.0659
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
0452AT
|
CO-TRIMOXAZOLE 40MG/ML|8MG/ML SUSP (CIR) SULFAMETHOXAZOLE|TR
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO-TRIMOXAZOLE
|
100ML
|
A
|
4.89
|
0.05
|
ML
|
200
|
BOTT
|
CIR
|
CIRON PHARMA
|
CWS
|
CAPSULE WHOLESALE
|
|
081220
|
SULPHONAMIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
SULPHONAMIDES
|
|
|
|
|
40
|
05415
|
BLEOMYCIN SULPHATE 15MG INJ (CIP/AHI)
|
BLEOMYCIN SULPHATE
|
BLEOMYCIN SULPHATE
|
15MG VIAL
|
BQ
|
44.85
|
44.85
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0742X
|
BENZTROPINE 1MG/ML INJ (CIR/AHI)
|
BENZTROPINE
|
BENZTROPINE
|
2ML
|
B
|
5.11
|
5.11
|
INJECTION
|
0
|
AMP
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283608
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP/AHI) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
2.91
|
2.91
|
RESPIRATORY
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
1.96
|
1.9572
|
BOTT
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2024-04-01
|
2026-03-31
|
|
INHALATION
|
6
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRA
|
|
|
|
|
42
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
2.07
|
2.07
|
BOTT
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2026-04-01
|
|
|
INHALATION
|
6
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRA
|
|
|
|
|
40
|
0884BL
|
IPRAVENT 0.25MG/ML RESP SOL (CIP/AHI) IPRATRO
|
IPRATROPIUM BROMIDE
|
IPRAVENT
|
20X2ML
|
A
|
32.70
|
1.64
|
RESPIRATORY
|
1
|
AMP
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
Nasal
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
0884BT
|
IPRAVENT 0.25MG/ML RESP SOL (CIP/AHI) IPRATRO
|
IPRATROPIUM BROMIDE
|
IPRAVENT
|
15ML
|
A
|
1.82
|
1.82
|
RESPIRATORY
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
Nasal
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
0884BT
|
IPRAVENT 0.25MG/ML RESP SOL (CIP) IPRATROPIUM
|
IPRATROPIUM
|
IPRAVENT
|
15ML
|
A
|
6.5
|
6.4968
|
BOTT
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
|
|
|
|
42
|
09122
|
IPRAVENT 0.25MG/ML RESP SOL (CIP) IPRATROPIUM
|
IPRATROPIUM
|
IPRAVENT
|
15ML
|
A
|
3.23
|
3.23
|
BOTT
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2026-04-01
|
|
|
ORAL INHALATION
|
6
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
|
|
|
|
41
|
09415
|
PANCURONIUM BROMIDE 2MG/ML INJ (CIR (B)
|
PANCURONIUM BROMIDE
|
PANCURONIUM BROMIDE
|
10X2ML
|
B
|
52.3
|
5.2301
|
AMP
|
0
|
BOX
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
41
|
1133FS
|
ATORVASTATIN 40MG TAB (CIR)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
2.01
|
0.0671
|
TAB
|
60
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
11529
|
GEMFIBROZIL 600MG TAB (CIP/AHI)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.68
|
TABLET
|
60
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.6809
|
TAB
|
60
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
42
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
C
|
40.91
|
0.68
|
TAB
|
60
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2026-04-01
|
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
40
|
1181EV
|
CILENOL 2.5MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
30'S
|
A
|
2.75
|
0.09
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
40
|
1182EQ
|
CILENOL 5MG TAB (CIR/AHI) BISOPROLOL
|
BISOPROLOL
|
CILENOL
|
30'S
|
A
|
4.24
|
0.14
|
TABLET
|
30
|
TAB
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
